Papers by Vanita Aroda · AgingResearch.News

Diabetologia2 Oct
Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Systematic reviewIndustry & policy
Paper
Diabetes Care2 Oct
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
ReviewIndustry & policy
Paper
JAMA Cardiology16 Sep
Efficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial
Randomised trial in 17,604 peopleSemaglutide
Paper
ADA Scientific Sessions 2026 Abstract6 Jun
Understanding the Lived Experiences of Dosing Practices among People Living with Obesity (PwO) Using Glucagon-Like Peptide 1 Receptor Agonists (GLP-1RAs) for Weight Loss (WL): A U.S. Qualitative Study
Study in peoplePopulations
Paper

ADA Scientific Sessions 2026 Abstract6 Jun
Effects of Mifepristone in People with Difficult-to-Control T2D and Hypercortisolism on GLP-1RAs
Trial in peopleInterventions
Paper
ADA Scientific Sessions 2026 Abstract5 Jun
Zenagamtide (Amycretin), a Novel Unimolecular GLP-1 and Amylin Receptor Agonist: Phase 2b Results in T2D
Trial in peopleInterventions
Paper
AHA Scientific Sessions 2025 Abstract3 Nov
Efficacy and Safety of Semaglutide According to Frailty Status in the SELECT Trial
Trial in peopleInterventions
Paper
ADA Scientific Sessions 2025 Abstract13 Jun
Relationship between Magnitude of Weight Loss and Cardiovascular Outcomes in the Diabetes Prevention Program (DPP) and Its Outcomes Study (DPPOS)
Trial in peopleInterventions
Paper